We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
In its fourth quarter 2024 investor letter, Parnassus Core Equity Fund emphasized stocks such as Vertex Pharmaceuticals ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a ...
StockStory.org on MSN3d
3 Reasons to Avoid VRTX and 1 Stock to Buy InsteadVertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the ...
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable. The ...
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...
Zacks.com on MSN1d
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained TodayVertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.
Zacks Investment Research on MSN2d
Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to KnowIn the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $495.29, marking a +1.42% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.49%.
Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...
Investor's Business Daily on MSN1d
Dow Jones Tumbles 537 Points On Trump Tariff Threats; S&P 500 Enters CorrectionThe Dow Jones Industrial Average tumbled 537 points Thursday as Wall Street reacted to tariff threats from President Trump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback